Vijay Gorantla to Immunosuppression
This is a "connection" page, showing publications Vijay Gorantla has written about Immunosuppression.
Connection Strength
2.463
-
Zamora R, Ravuri SK, Plock JA, Vodovotz Y, Gorantla VS. Differential inflammatory networks distinguish responses to bone marrow-derived versus adipose-derived mesenchymal stem cell therapies in vascularized composite allotransplantation. J Trauma Acute Care Surg. 2017 07; 83(1 Suppl 1):S50-S58.
Score: 0.588
-
Plock JA, Schnider JT, Zhang W, Schweizer R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY, Rubin PJ, Marra KG, Gorantla VS. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. Transplantation. 2015 Sep; 99(9):1765-73.
Score: 0.518
-
Schnider JT, Weinstock M, Plock JA, Solari MG, Venkataramanan R, Zheng XX, Gorantla VS. Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential. Clin Dev Immunol. 2013; 2013:495212.
Score: 0.434
-
Fisher JD, Balmert SC, Zhang W, Schweizer R, Schnider JT, Komatsu C, Dong L, Erbas VE, Unadkat JV, Aral AM, Acharya AP, Kulahci Y, Turnquist HR, Thomson AW, Solari MG, Gorantla VS, Little SR. Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation. Proc Natl Acad Sci U S A. 2019 12 17; 116(51):25784-25789.
Score: 0.174
-
Weissenbacher A, Cendales L, Morelon E, Petruzzo P, Brandacher G, Friend PJ, Gorantla V, Kaufman C, Krapf J, Levin LS, Vrakas G, Schneeberger S. Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation. Transplantation. 2018 08; 102(8):1250-1252.
Score: 0.158
-
Breidenbach WC, Meister EA, Becker GW, Turker T, Gorantla VS, Hassan K, Kaplan B. A Statistical Comparative Assessment of Face and Hand Transplantation Outcomes to Determine Whether Either Meets the Standard of Care Threshold. Plast Reconstr Surg. 2016 Jan; 137(1):214e-222e.
Score: 0.132
-
Liu Q, Wang Y, Nakao A, Zhang W, Gorantla V, Zheng XX. Heart allograft tolerance induced and maintained by vascularized hind-limb transplant in rats. Clin Dev Immunol. 2013; 2013:483856.
Score: 0.109
-
Losee JE, Fletcher DR, Gorantla VS. Human facial allotransplantation: patient selection and pertinent considerations. J Craniofac Surg. 2012 Jan; 23(1):260-4.
Score: 0.100
-
Schneeberger S, Gorantla VS, Hautz T, Pulikkottil B, Margreiter R, Lee WP. Immunosuppression and rejection in human hand transplantation. Transplant Proc. 2009 Mar; 41(2):472-5.
Score: 0.082
-
Schneeberger S, Landin L, Kaufmann C, Gorantla VS, Brandacher G, Cavadas P, Lee WP, Breidenbach WC, Margreiter R. Alemtuzumab: key for minimization of maintenance immunosuppression in reconstructive transplantation? Transplant Proc. 2009 Mar; 41(2):499-502.
Score: 0.082
-
Wachtman GS, Wimmers EG, Gorantla VS, Lin CH, Schneeberger S, Unadkat JV, Zheng XX, Brandacher G, Lee WP. Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. Transplant Proc. 2011 Nov; 43(9):3541-4.
Score: 0.025
-
Shores JT, Brandacher G, Schneeberger S, Gorantla VS, Lee WP. Composite tissue allotransplantation: hand transplantation and beyond. J Am Acad Orthop Surg. 2010 Mar; 18(3):127-31.
Score: 0.022
-
Schneeberger S, Gorantla VS, van Riet RP, Lanzetta M, Vereecken P, van Holder C, Rorive S, Remmelink M, Le Moine A, Abramowicz D, Zelger B, Kaufman CL, Breidenbach WC, Margreiter R, Schuind F. Atypical acute rejection after hand transplantation. Am J Transplant. 2008 Mar; 8(3):688-96.
Score: 0.019
-
Lanzetta M, Petruzzo P, Dubernard JM, Margreiter R, Schuind F, Breidenbach W, Nolli R, Schneeberger S, van Holder C, Gorantla VS, Pei G, Zhao J, Zhang X. Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol. 2007 Jul; 18(1):1-6.
Score: 0.018